BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 05/10/1999

FDA Releases Draft Guidance on Breast Prostheses Labeling and Clinical Data

The FDA has made available a draft guidance document outlining requirements for preclinical and clinical data and labeling for breast prostheses, including silicone, saline, and alternative-filled implants used for breast augmentation, reconstruction, and revision.

Source: Federal Register — Food and Drug AdministrationOpen original release →